Drugs / NATRUM PHOSPHORICUM
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT07054697 | Jan 2017 → Dec 2024 | autism spectrum disorder | Aditi Chadha | Completed | No outcome recorded |
| Phase 4 | NCT07161804 | Dec 2016 → Dec 2024 | autism spectrum disorder | Holistic Homoeopathic Clinic and Research Center | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07813013 | Nov 2026 → Nov 2028 expected | colorectal neoplasm, polyp of colon | Westmead Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Natrum phosphoricum | “Thuja officinalis Vaccininum Causticum Argentum nitricum Tuberculinum Stramonium Staphysagria Arum triphyllum Bacillinum Cina Carcinocin Cuprum Metallicum Ambera grisea...” NCT07161804 ↗1“NATRUM PHOSPHORICUM” NCT07054697 ↗ |
| Known as | Dibasic sodium phosphate heptahydrate | “A single Fleet sodium phosphate enema (monobasic sodium phosphate monohydrate 19 g and dibasic sodium phosphate heptahydrate 7 g in 118 mL of saline) is administered once,...” NCT07813013 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “homeopathic treatment” NCT07161804 ↗ |
| Route | Other | “is administered once, intra-procedurally, into the right colon through the colonoscope working channel” NCT07813013 ↗ |